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Abstract: Skeletal muscle glucose uptake and glucose metabolism are impaired in insulin resistance.
Mechanical overload stimulates glucose uptake into insulin-resistant muscle; yet the mechanisms
underlying this beneficial effect remain poorly understood. This study examined whether a
differential partitioning of glucose metabolism is part of the mechanosensitive mechanism underlying
overload-stimulated glucose uptake in insulin-resistant muscle. Mice were fed a high-fat diet to
induce insulin resistance. Plantaris muscle overload was induced by unilateral synergist ablation.
After 5 days, muscles were excised for the following measurements: (1) [3H]-2-deoxyglucose
uptake; (2) glycogen; 3) [5-3H]-glucose flux through glycolysis; (4) lactate secretion; (5) metabolites;
and (6) immunoblots. Overload increased glucose uptake ~80% in both insulin-sensitive and
insulin-resistant muscles. Overload increased glycogen content ~20% and this was enhanced to
~40% in the insulin-resistant muscle. Overload did not alter glycolytic flux, but did increase muscle
lactate secretion 40–50%. In both insulin-sensitive and insulin-resistant muscles, overload increased
6-phosphogluconate levels ~150% and decreased NADP:NADPH ~60%, indicating pentose phosphate
pathway activation. Overload increased protein O-GlcNAcylation ~45% and this was enhanced
to ~55% in the insulin-resistant muscle, indicating hexosamine pathway activation. In conclusion,
insulin resistance does not impair mechanical overload-stimulated glucose uptake but does alter the
metabolic fate of glucose in muscle.
Keywords: exercise; glucose transporter; glycogen; glycolysis; hexosamine pathway; lactate; pentose
phosphate pathway
1. Introduction
Exercise training is one of the most well-established therapeutic strategies for the treatment of
progressive metabolic diseases such as type 2 diabetes [1–8]. Importantly, while previous work has
demonstrated that resistance exercise training and chronic mechanical muscle loading (overload)
stimulate glucose uptake into both insulin-sensitive and insulin-resistant skeletal muscle [9,10],
the cellular or metabolic adaptations that underlie these beneficial effects are still largely unknown.
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Glucose uptake into skeletal muscle is regulated by the presence of cell surface glucose transporters
as well as its metabolic fate, including: (1) storage as glycogen; (2) flux via glycolysis; (3) the pentose
phosphate pathway; and (4) the hexosamine pathway. Importantly, studies have linked excessive
muscle glycogen accumulation and increased glucose flux through the hexosamine pathway with the
development of muscle insulin resistance [11–15], highlighting the importance of glucose metabolism in
regulating future increases in muscle glucose uptake. In addition, changes in glucose metabolism such
as increased glycolytic flux and activation of the pentose phosphate pathway have been linked with
enhanced cellular growth in a variety of cell types [16–19]. Despite the beneficial effects of resistance
training/overload on systemic glucose homeostasis and muscle glucose uptake, little is known regarding
its effects on muscle glucose metabolism. Previous work has shown that resistance training/overload
results in small but inconsistent (0–45%) increases in muscle glycogen levels [6,9,10,20–23], while chronic
muscle loading has been shown to increase glycolytic flux (30–60%) [9]. Whether overload directs
glucose flux into other metabolic pathways, and whether this partitioning of glucose is affected by
insulin resistance, has not yet been examined.
The primary purpose of this study was to determine if the ability of overload to stimulate
glucose uptake in insulin-resistant skeletal muscle is associated with a differential partitioning of
glucose into metabolic pathways. We hypothesized that: (1) glycogen content and glycogen synthesis
rates would be increased by overload, and not affected by insulin resistance; (2) glycolytic flux and
pentose phosphate pathway activity would be increased by overload and not affected by insulin
resistance; and (3) hexosamine pathway activity would be increased in insulin-resistant muscle, and
decreased by overload. The main findings from this study demonstrate that mechanical overload
stimulates an increase in muscle glycogen synthesis, lactate secretion, the pentose phosphate pathway
and the hexosamine pathway. Insulin resistance impaired overload-stimulated muscle glycogen
synthesis; did not alter the overload-stimulated increase in lactate secretion, or activation of the
pentose phosphate pathway; but enhanced the overload-stimulated activation of the hexosamine
pathway. Collectively, these findings highlight the importance of glucose partitioning as part of the
mechanosensitive mechanism underlying overload-stimulated muscle glucose uptake.
2. Results
2.1. High-Fat Diet-Induced Mouse Model of Insulin Resistance
To determine whether insulin resistance impairs mechanical overload-stimulated skeletal muscle
glucose uptake and/or glucose metabolism, a rodent model of high-fat diet-induced insulin resistance
was utilized. Male C57BL/6J mice were fed either a low-fat diet (LFD) or high-fat diet (HFD) ad libitum
for 12 weeks. Mice fed the HFD exhibited higher body weights (~60%), fasted blood glucose levels
(~70%), fasted serum insulin levels (~450%) and HOMA-IR values (~900%) compared to LFD controls,
demonstrating the development of obesity and whole body insulin resistance (Figure 1A–D). To assess
the development of skeletal muscle insulin resistance, isolated plantaris muscles were incubated in
buffer containing [3H]-2-deoxyglucose in the absence or presence of a submaximal dose of insulin.
Insulin increased glucose uptake ~100% in muscles from the LFD mice, but only ~60% in muscles from
the HFD mice (Figure 1E), demonstrating that the HFD induced plantaris muscle insulin resistance.
2.2. Insulin Resistance Does Not Impair Overload-Stimulated Muscle Glucose Uptake
To determine whether insulin resistance impairs overload-stimulated muscle glucose uptake,
mice underwent unilateral synergist ablation surgery to induce plantaris muscle overload. After
5 days, muscles were removed and immediately weighed. Overload increased plantaris muscle
weight ~40% in LFD mice, and this overload-stimulated increase in muscle weight was ~2% greater in
HFD mice (Figure 2A). To determine whether insulin resistance impairs overload-stimulated glucose
uptake, muscles were incubated in buffer containing [3H]-2-deoxyglucose in the absence of insulin.
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Overload increased glucose uptake ~80% in muscles from both the LFD and HFD mice (Figure 2B),
demonstrating that insulin resistance does not impair overload-induced muscle glucose uptake.
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Figure 1. High-fat diet-induced mouse model of obesity and plantaris muscle insulin resistance.
Male C57BL/6J mice were fed a low-fat diet (LFD) or high-fat diet (HFD) for 12 weeks. Following an
overnight fast, mice were weighed (A). Blood was collected from the tail to assess glucose (B) and insulin
levels (C). The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated (D).
Plantaris muscles were excised and [3H]-2-deoxy-d-glucose uptake assessed in the absence (–) or
presence of submaximal insulin (Ins; 600 µU/mL = 4167 pM) (E). Data are mean ± standard deviation.
Statistical analysis was performed using unpaired t-tests (A–D; N = 40–47 mice) or a 2-way ANOVA
with Tukey’s post-hoc analysis (E; N = 7 muscles/group). p < 0.05 * vs. LFD; $ vs. –.
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Figure 2. Insulin resistance does not impair overload-stimulated increases in plantaris muscle mass or
glucose uptake. After 12 weeks of high-fat diet (HFD) feeding, mice underwent unilateral synergist
ablation surgery to induce overload (OVL) of the plantaris muscle. Five days later isolated plantaris
muscles were weighed (A), and [3H]-2-deoxy-d-glucose uptake assessed in the absence of insulin (B).
Data are mean ± standard deviation. Statistical analysis was performed using a 2-way ANOVA with
Tukey’s post-hoc analysis. N = 38–40 muscles/group (A), or 10 muscles/group (B). p < 0.05 # vs.
sham (Sh); * vs. low-fat diet (LFD).
2.3. Insulin Resistance Does Not Impair Overload-Stimulated Glucose Transporter Expression
Glucose uptake into muscle requires both transport across the cell surface by glucose transporter
(GLUT) proteins as well as phosphorylatio by the enzy hex e. Strikingly, recent work
demonstrated that the T isoform expressed in skeletal muscle, GLUT4, is ot necessary
for overload-stimulated muscle gl cose uptake [24]. Instead, studies have shown that overload
stimulates an increase in the mRNA and protein levels of GLUT1, GLUT3, GLUT6, and GLUT10 in
insulin-sensitive mouse muscle [24,25]. To determine whether insulin resistance alters the effects of
overload on GLUT isoform or hexokinase II protein levels, immunoblots were performed (Figure 3A–F).
While overload did not increase GLUT1 protein levels in muscles from LFD mice, it increased GLUT1
levels ~70% in muscles from HFD mice (Figure 3A). Overload increased GLUT3 levels ~65% in muscles
from LFD mice, and increased GLUT3 levels more in muscles from the HFD mice (~100%; Figure 3B).
Overload incr ased GLUT6 levels ~350% and GLUT10 levels ~35% in muscl s from both LFD and
HFD mice (Figure 3D,E). Neither GLUT4 nor hexokin se II prote levels were altered by overload
in muscles from either the LFD or HFD ice (Figure 3C,F). Collectively these findings suggest that
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increases in GLUT1, GLUT4 or hexokinase II protein levels are not part of the mechanism underlying
overload-stimulated muscle glucose uptake.
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Figure 3. Insulin resistance does not impair overload-stimulated increases in glucose transporter protein
levels. After 12 weeks of high-fat diet (HFD) feeding, mice underwent unilateral synergist ablation
surg ry to induce overload (OVL) of the plantaris muscle. Five days later, muscles were processed for
immunobl t (IB) analysis of glucose transporter 1 (A: GLUT1); (B) GLUT3; (C) GLUT4; (D) GLUT6;
(E) GLUT10; and (F) h xokinase II (HXII). Data are mean ± standard deviation. Statistical analysis was
performed using a 2-way ANOVA with Tukey’s post-hoc analysis. N = 7–10 muscles/group. p < 0.05 #
vs. Sham (Sh); * vs. low-fat diet (LFD); @ = main effect.
2.4. Insulin Resistance Enhances Overload-Stimulated Accumulation of Muscle Glycogen
Skeletal muscle glycogen content is inversely related to glucose uptake [26]. To determine
whether lower glycogen levels are part of the mechanism underlying overload-stimulated muscle
glucose uptake, muscle glycogen levels were assessed using a hexokinase-based reagent. Overload
increased glycogen content ~25% in muscles from LFD mice and this increase was greater (~40%)
in muscles from HFD mice (Figure 4A), demonstrating that lower glycogen content is not part of
the echanism underlying verload-stimulated glucos uptake. T d termine whether th higher
glycogen content observed in the overload-stimulated muscles was due to increased glycogen synthesis,
muscles wer i cubated i [5-3H]-glucose for 1 h, and the incorporation f the radiolabel into glycogen
(i.e., [5-3H]-glycogen) assessed. In response to overload, glycogen synthesis increased ~25% in muscles
from LFD mice, but only trended towards a significant increase (~12%; p = 0.058) in muscles from HFD
mice (Figure 4B). Thus, the higher glycogen content seen in the overload-stimulated muscles from the
HFD mice is not due to an increase in glycogen synthesis rates.
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Figure 4. Insulin resistance enhances overload-stimulated muscle glycogen accumulation.
After 12 weeks of high-fat diet (HFD) feeding, mice underwent unilateral synergist ablation surgery
to induce overload (OVL) of the plantaris muscle for 5 days. (A) Total muscle glycogen content was
assessed using a hexokinase-based assay; or (B) muscles were incubated in [5-3H]-glucose to determine
glycogen synthesis. Data are mean ± standard deviation. Statistical analysis was performed using a
2-way ANOVA with Tukey’s post-hoc analysis. N = 10–12 muscles/group. p < 0.05 # vs. Sham (Sh);
* vs. low-fat diet (LFD).
2.5. Overload Does Not Alter Glycolytic Flux in Insulin Sensitive or Insulin Resistant Muscle
Glucose is utilized in several major metabolic pathways, and the partitioning of glucose into
these different pathways can have critical consequences for future increases in muscle glucose uptake.
Glycolysis is a key glucose utilizing pathway in skel tal muscle as it plays a critical role in enerating
ATP under both oxygen abundant and hypoxic condition . To determine whether increased glucose
flux through glycolysis is part of the mechanism underlying overload-stimulated m scle glucose
uptake, muscles were incubated in [5-3H]-glucose and the generation of [3H]-H2O from the enolase
reaction utilized to calculate muscle glycolytic flux rate. As shown in Figure 5A, overload did not
increase glycolytic flux in muscles from either LFD or HFD mice. To further assess glucose utilization
via glycolysis downstream of the enolase reaction, buffer lactate levels were measured as an indicator
of muscle lactate secretion. As shown in Figure 5B, ove load increased muscle lactate secretion 40–50%
in muscles from both LFD and HFD mice.
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Figure 5. Insulin resistance does not impair muscle glycolytic flux, or overload-stimulated muscle
lactate secretion. After 12 weeks of high-fat diet (HFD) feeding, mice underwent unilateral synergist
ablation surgery to induce overload (OVL) of the plantaris muscle for 5 days. (A) Muscles were
incubated in [5-3H]-glucose to determine glucose flux through glycolysis. (B) Buffer lactate levels were
measured at the end of the glycolytic flux assay as an indicator of muscle lactate secretion. Data are
mean ± standard deviation. Statistical analysis was performed using a 2-way ANOVA with Tukey’s
post-hoc analysis. N = 12 muscles/group. p < 0.05 # vs. Sham (Sh).
2.6. Overload-Stimulated Activation of the Pentose Phosphate Pathway Is Not Impaired by Insulin Resistance
The pentose phosphate pathway is a glucose utilizing metabolic pathway that generates molecules
critical for muscle growth, including NADPH for reductive biosynthesis reactions and key metabolic
precursors for nucleotide and i o acid synthesis. To assess whether activation of the pentos
phosphate pathway could be part of the mechanism underlying overload-stimulated muscle glucose
uptake, the protein levels of the initiating enzyme of this pathway, glucose-6-phosphate dehydrogenase
(G6PD), were assessed by immunoblot analysis. As shown in Figure 6A, overload increased G6PD
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levels ~140% in muscles from LFD mice, and this effect was attenuated in muscles from HFD mice
(only a ~80% increase). To further investigate the effects of insulin resistance and overload on the
pentose phosphate pathway, several key pentose phosphate pathway metabolites were assessed by
UPLC-MRM/MS. In muscles from both LFD and HFD mice, overload increased 6-phosphogluconate
levels (140–160%; Figure 6B). In addition, overload decreased NADP levels ~40% and increased
NADPH levels ~65% in muscles from LFD mice, and decreased NADP levels ~55% and increased
NADPH levels ~20% in muscles from the HFD mice (Figure 6C,D). When evaluated together, overload
decreased the ratio of NADP:NADPH ~60% in muscles from both LFD and HFD mice (Figure 6E).
Collectively, these findings suggest that overload activates the pentose phosphate pathway in skeletal
muscle and that this activation is not impaired by insulin resistance.
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Figure 6. Insulin resistance does not impair overload-stimulated activation of the pentose phosphate
pathway. After 12 weeks of high-fat diet (HFD) feeding, ice underwent unilateral synergist ablation
surgery to induce overload (OVL) of the plantaris muscle for 5 days. (A) Muscles were excised and the
protein content of glucose-6-phosphate dehydrogenase (G6PD) determined by immunoblot (IB) analysis.
The G6PD antibody was validated using mouse tibialis anterior muscle samples overexpressing G6PDx
(OE) or empty vector-transfected controls (-). (B–D) Ultra performance liquid chromatography/ multiple
reaction monitoring-mass spectrometry (UPLC/MRM-MS) was used to measure 6-phosphogluconate,
NADP and NADPH. (E) The ratio of NADP:NADPH was calculated. Data are mean ± standard
deviation. Statistical analysis was performed using a 2-way ANOVA with Tukey’s post-hoc analysis.
N = 7–9 muscles/group. p < 0.05 # vs. Sham (Sh); * vs. low-fat diet (LFD).
2.7. Overload-Stimulated Activation of the Hexosamine Pathway Is Enhanced by Insulin Resistance
The hexosa i th ay is an additional glucose utilizing metabolic pathway that generates
UDP-N-acetylglucosamin and other nucleot d hexosami es for the O-linked GlcNAcylation of
proteins. To assess whether activation of the hexosamine pathway could be part of the mechanism
underlying overload-stimulated muscle glucose uptake, immunoblots were performed to assess the
protein levels of the initiating enzyme of this pathway, glutamine fructose-6-phosphate transaminase 1
(GFPT1). Overload increased GFPT1 levels ~50% in muscles from both LFD and HFD mice (Figure 7A).
To further investigate the effects of insulin resistance and overload on the hexosamine pathway
in skeletal muscle, immunoblots were performed to assess total muscle protein O-GlcNAcylation.
As shown in Figure 7B, overload increased protein O-GlcNAcylation ~45% in muscles from LFD mice,
and this effect was greater in muscles from the HFD mice (increased ~55%). Thus, collectively these
findings suggest that overload activates the hexosamine pathway in skeletal muscle and that this effect
is enhanced by insulin resistance.
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Figure 7. Insulin resistance enhances overload-stimulated activation of the hexosamine biosynthetic
pathway. After 12 weeks of high-fat diet (HFD) feeding, mice underwent unilateral synergist ablation
surgery to induce overload (OVL) of the plantaris muscle for 5 days. (A) Muscles were excised
and th pr tein content of glutamine fructose-6-phosphate transaminase 1 (GFPT1) det rmi ed by
immunobl t (IB) analysis. The GFPT1 antibody wa validated using mouse tibialis anteri r muscle
samples overexpressing GFPT1 (OE) or empty vector-transfected controls (-). (B) Immunoblots were
also performed to assess total muscle O-GlcNAc-modified proteins. Data are mean ± standard
deviation. Statistical analysis was performed using a 2-way ANOVA with Tukey’s post-hoc analysis.
N = 8–10 muscles/group. p < 0.05 # vs. Sham (Sh); * vs. low-fat diet (LFD).
3. Discussion
The major findings from this study demonstrate that HFD-induced insulin resistance impairs
overload-stimulated muscle glycogen synthesis; does not alter overload-stimulated increases in lactate
secretion or activation of the pentose phosphate pathway; but does enhance the overload-stimulated
activation of the hexosamine pathway. Collectively, these findings highlight the importance of glucose
metabolism s part of the mechanosensit ve m ch nism nderlying overload-stimulated muscle
glucose uptake.
The glucose transporter that mediates overload-stimulated muscle glucose uptake is presently
unknown. However, findings from this study demonstrate that overload increases GLUT1, GLUT3,
GLUT6 and GLUT10 protein levels in insulin resistant muscle (Figure 3), suggesting that one or more
of these GLUT isoforms may be responsible for this effect. Surprisingly, in this study, overload failed to
significantly increase GLUT1 levels in muscles from the LFD mice (Figure 3A). The reason underlying
this difference in finding is presently not clear, but is likely not due to the sex of mice, as we have
previously observed a significant increase in GLUT1 protein levels following overload in muscles from
both male and female mi e [24]. The abund nce of GLUT3, GLUT6 or GLUT10 protein in muscle
relative to the abundance of other GLUT isoforms s not yet bee d termined. However, pr vious
work has demonstrated that GLUT3 is localized to the cell surface in myotubes and has a high affinity
for 2-deoxyglucose (Km = 1.8 mM) and d-glucose (Km = 1.4 mM) [27–29], raising the possibility that the
65–100% increase in GLUT3 levels induced by overload could lead to a substantial increase in muscle
glucose uptake. The subcellular localization of GLUT6 and GLUT10 in skeletal muscle has not yet been
investigated. However previous work has demonstrated that GLUT6 can be localized to both the cell
surface and an intracellular compartment (e.g., lysosome) depending on the cell type [30,31], while to
date GLUT10 has been detected primarily in mitochondria in smooth muscle cells [32]. Future studies
assessing the localization of these GLUTs in skeletal muscle in response to overload as well as studies
utilizing novel muscle-specific GLUT isoform knockout mice are needed to definitively determine the
GLUT responsible for overload-stimulated muscle glucose uptake.
In this study, overload stimulated glycogen accumulation 25–45% in plantaris muscles from the
LFD and HFD fed mice (Figure 4A). This increase in muscle glycogen content was consistent with
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several studies from both humans and rats that demonstrated a 15–45% increase in muscle glycogen
content following 6–16 weeks of resistance exercise training [10,20,23,33]; whereas they were in contrast
with other 6-week resistance training studies in humans that demonstrated no effect of muscle glycogen
levels [21,22]. These findings are also in contrast with previous work that demonstrated that 4 days of
overload was not sufficient to increase glycogen content in soleus muscles from healthy or chow diet
overeating-induced insulin resistant mice [9]. The reason underlying this discrepancy in findings is
presently unknown but could be due to differences in mouse strain (i.e., C57BL/6J vs. Swiss albino)
and/or muscle examined (i.e., plantaris vs. soleus).
Muscle protein synthesis is a high ATP demanding metabolic process. Thus, we hypothesized
that mechanical overload might increase glucose utilization through glycolysis to fuel the increased
energetic demand of protein synthesis and muscle hypertrophic growth. Intriguingly, while overload
did not increase muscle glycolytic flux through the enolase reaction (Figure 5A); it did increase lactate
secretion in muscles from both the LFD and HFD mice (Figure 5B). Taken together these results
could possibly suggest that overload decreases muscle glucose oxidation. Unfortunately, in this study
measures of glucose oxidation were not possible due to the inability to capture labelled CO2 gas with
the current muscle incubation apparatus. Future studies will need to be performed to address the
contribution of substrate oxidation to overload-stimulated changes in glucose metabolism in both
insulin-sensitive and insulin-resistant muscles.
In both insulin-sensitive and insulin-resistant muscle, overload increased G6PD protein levels
~140%, 6-phosphogluconate levels 140–160% and NADPH levels 20–65% (Figure 6), suggesting that
overload stimulates an increase in glucose flux through the pentose phosphate pathway in skeletal
muscle. The results from this study are consistent with work performed in rat skeletal muscle that
demonstrated a 100–350% increase in G6PD activity 2 days after a single bout of downhill treadmill
running [34], as well as an ~20% increase in ribose-5-phosphate levels immediately after 10 min of
high intensity tetanic contractions [35]. Thus, collectively these findings support the idea that the
pentose phosphate pathway is an exercise- and overload-responsive glucometabolic pathway in muscle.
Future work is needed to directly determine the amount of glucose that is redirected into this pathway
in muscle following overload and resistance exercise training.
While activation of the hexosamine pathway has been linked to the development of insulin
resistance [15,36], inhibition of this pathway has been linked to an increase in insulin sensitivity [36].
Thus, we hypothesized that the HFD would increase GFPT1 and total protein O-GlcNAcylation levels
in muscle, and that these effects would be reversed by overload. In contrast, the results of this study
demonstrated that while muscles from the HFD mice did not have increased GFPT1 nor increased
total protein O-GlcNAcylation levels (Figure 7), both GFPT1 and O-GlcNAcylation were increased by
overload (Figure 7). Thus, additional studies should be performed to determine which proteins are
O-GlcNAcylated in muscle in response to overload to fully assess the role of this pathway to chronic
loading-stimulated muscle adaptations.
The glucose uptake and glucose metabolism measurements presented in this study were generated
using an ex vivo skeletal muscle model system. This model system was chosen because it provides the
ability to control substrate availability (i.e., extracellular glucose concentrations) while eliminating the
possible contribution of systemic factors (e.g., changes in blood flow, neuronal activity or circulating
hormones such as insulin). Thus, by design this model does not fully recapitulate the multitude of
factors that could influence loading-stimulated muscle glucose uptake or glucose metabolism in the
in vivo environment. Therefore, the findings from this study should be viewed as a crucial starting
point for future studies that would assess loading-stimulated changes in muscle metabolism in living
animal or human subjects that were both insulin sensitive and insulin resistant.
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4. Materials and Methods
4.1. Animals
Experiments were performed in accordance with the East Carolina University Institutional Animal
Care and Use Committee (Animal Use Protocol #s: P066a and P066b) and the National Institutes of
Health Guidelines for the Care and Use of Laboratory Animals. Male C57BL/6J mice (~6 weeks old)
were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and fed either a standard chow,
14% kcal low-fat diet (LFD; Prolab®RMH3000, cat#5P75*, PMI Nutritional International, St. Louis,
MO, USA) or a 60% kcal high-fat diet (HFD; cat#D12492, Research Diets, New Brunswick, NJ, USA) for
12 weeks. Only male mice were utilized in this study because previous work has indicated that male
mice exhibit greater obesity, glucose intolerance and insulin resistance in response to high-fat feeding
compared to female mice (data not shown) [37–40]. Male CD-1 mice (~6 weeks old) were obtained
from Charles River Laboratories and provided standard chow. Food and water were available ad
libitum. Mice were housed in cages at 21–22 ◦C with a 12 h light/dark cycle.
4.2. Systemic Insulin Resistance Assessment
After 12 weeks of diet intervention, mice were fasted overnight (12–14 h), weighed, and blood
samples collected from the tail vein to assess glucose levels using a glucometer (OneTouch Ultra2,
LifeScan Inc., Milpitas, CA, USA), and insulin levels by enzyme-linked immunosorbent assay
(cat#EZRMI-13K, EMD Millipore, Burlington, MA, USA). The homeostatic model assessment of
insulin resistance (HOMA-IR) was calculated by multiplying fasted blood glucose (mM) by fasted
serum insulin (mU/L) and dividing by 22.5.
Mice that did not clearly segregate into an LFD, insulin-sensitive or HFD, insulin-resistant
group were excluded from further experiments (excluded: N = 14/60 LFD mice; N = 13/60 HFD
mice). All remaining mice were randomly assigned to one of the following experimental groups:
(1) insulin-stimulated muscle glucose uptake; (2) overload-stimulated muscle glucose uptake and total
glycogen; (3) intracellular protein expression levels; (4) glycolytic flux, lactate secretion and glycogen
synthesis; or (5) pentose phosphate pathway metabolites.
4.3. Unilateral Synergist Ablation Surgery
Plantaris muscle mechanical overload was induced via unilateral ablation of synergist muscles
using methods previously described by our lab [24,41]. Mice were anaesthetized with isoflurane
(2–3%) and the distal two-thirds of the gastrocnemius and soleus surgically ablated. A sham surgery
was performed on the contralateral leg. After 5 days, mice were fasted overnight, anesthetized with
pentobarbital sodium (90–100 mg/kg body weight) for 40 min and euthanized by cervical dislocation.
Muscles were excised and weighed to ±0.1 g using an analytical balance (Mettler-Toledo XS105,
Columbus, OH, USA), prior to additional experimental perturbations as described below.
4.4. Muscle [3H]-2-Deoxyglucose Uptake
Insulin- and overload-stimulated [3H]-2-deoxyglucose uptake was assessed in isolated muscles
using methods previously described by our lab [24,42]. For insulin-stimulated glucose uptake,
muscles were incubated in continuously gassed (95% O2, 5% CO2), 37 ◦C Krebs-Ringer-Bicarbonate
(KRB) buffer containing: 117 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4,
and 24.6 mM NaHCO3 supplemented with 2 mM pyruvate for 70 min, and incubated in the presence or
absence of submaximal insulin (600 µU/mL = 4167 pM; cat#11376497001, Sigma-Aldrich, St. Louis, MO,
USA) for 20 min. For overload-stimulated glucose uptake, muscles were incubated in continuously
gassed, 37 ◦C KRB buffer+ 2 mM pyruvate for 90 min. To assess glucose uptake, muscles were incubated
in continuously gassed, 30 ◦C KRB buffer containing 1.5µCi/mL [3H]-2-deoxy-d-glucose (cat#NET54900,
Perkin Elmer, Waltham, MA, USA), 1 mM 2-deoxy-d-glucose, 0.45 µCi/mL [14C]-mannitol (Perkin Elmer,
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cat#NEC314), and 7 mM mannitol for 10 min. Muscles were frozen in liquid nitrogen. Frozen muscles
were weighed, solubilized in 1.0 N NaOH at 80 ◦C for 15 min, and the solution neutralized with 1.0 N HCl.
For overload-stimulated muscle samples, an aliquot was removed to assess total muscle glycogen as
described below. The remaining fraction was centrifuged at 10,000× g for 1 min. Aliquots were removed
for scintillation counting of the [3H] and [14C] labels, and [3H]-2-deoxyglucose uptake calculated.
4.5. Muscle Glycogen Content
Glycogen content was determined from aliquots of muscle lysate taken from ex vivo
overload-stimulated glucose uptake experiments as described above. Aliquots were incubated
in 3.33 M HCl at 95 ◦C for 120 min and neutralized by the addition of 2 M NaOH and 1.5 M Tris
(pH 7.8). A hexokinase-based reagent (cat#2820-3, Eagle Diagnostics, Cedar Hill, TX, USA) was added,
and glycogen content measured spectrophotometrically at 340 nm using a SpectraMax M4 multimode
plate reader (Molecular Devices, San Jose, CA, USA).
4.6. Muscle Glycolytic Flux and Lactate Secretion
Glycolytic flux rates were assessed in isolated muscles by measuring the rate of [5-3H]-glucose
conversion to [3H]-H2O using methods adapted from those previously described [43]. Plantaris muscles
were incubated in continuously gassed, 37 ◦C KRB + 2 mM pyruvate buffer for 90 min, and KRB
buffer containing 2.75 µCi/mL d-[5-3H]-glucose (cat# NET531, Perkin Elmer, Waltham, MA, USA) and
5.5 mM d-glucose for 60 min. Muscles were removed and frozen in liquid nitrogen to assess glycogen
synthesis as described below. Aliquots of buffer were collected to assess glycolytic flux and muscle
lactate secretion. For glycolytic flux, [5-3H]-glucose was separated from [3H]-H2O using Dowex-1
borate mini-columns. Dowex-1 borate was generated by washing Dowex 1 × 8 chloride (cat#44340,
Millipore Sigma, St. Louis, MO, USA) with sodium tetraborate. [3H]-H2O levels were assessed by
liquid scintillation counting, and glycolytic flux rates calculated and normalized to pre-incubation
muscle weights. For muscle lactate secretion, buffer lactate levels were assessed using a lactate
colorimetric/fluorometric assay kit (cat# K607-100, Biovision Inc., Milpitas, CA, USA).
4.7. Muscle Glycogen Synthesis
Muscle glycogen synthesis rates were assessed by measuring the rate of [5-3H]-glucose
incorporation into glycogen using methods previously described [44]. Frozen muscles from the
glycolytic flux experiment were solubilized in 30% KOH at 95 ◦C for 20 min. Glycogen was
precipitated by the addition of 50 µL of 5% glycogen (Sigma-Aldrich, cat#G8876), 100% EtOH
(final concentration = 70%), and incubating at −20 ◦C overnight. Samples were centrifuged at
8900× g for 20 min to pellet glycogen. Pellets were washed with 66% EtOH and dissolved in deionized
water. Samples were spotted onto P81 grade ion exchange chromatography paper (cat#3698-325,
GE Whatman, Marlborough, MA, USA), washed with 66% EtOH, and air-dried. [5-3H]-glycogen was
measured via liquid scintillation counting, and glycogen synthesis rates calculated and normalized to
muscle weight.
4.8. Pentose Phosphate Pathway Metabolites
Whole frozen plantaris muscles were sent to Creative Proteomics (Shirley, NY, USA) for the
quantification of NADP, NADPH, and 6-phosphogluconate levels. Muscles were weighed and then
homogenized in cold 80% aqueous MeOH using a MM 400 mill mixer 2 × 1 min. Samples were
centrifuged at 21,130× g at 5 ◦C, and 400 µL of clear supernatant removed and mixed with 100 µL of a
13C10-GTP (internal standard) solution and 250 µL chloroform. The mixture was vortexed for 1 min
and then centrifuged at 21,130× g at 5 ◦C for 10 min. The upper aqueous phase was removed and
dried under a nitrogen gas flow. The residue was reconstituted in 200 µL of 50% acetonitrile. A 10-µL
aliquot of each sample was injected into a HILIC (hydrophilic interaction liquid chromatography)
column (2.1 × 150 mm, 1.7 µm) for gradient elution with ammonium buffer (mobile phase A) and
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acetonitrile (mobile phase B). The efficient gradient was from 75% B to 15% B in 12 min, with a flow rate
of 300 µL/min and a column temperature of 30 ◦C. Metabolites were detected by UPLC-MRM/MS with
(-) ion detection using a Dionex 3400 UHPLC system coupled to a 4000 QTRAP mass spectrometer.
4.9. Immunoblot Analyses
Immunoblot analyses were performed using standard methods as described by our lab [24,41,42].
Frozen muscles were homogenized in buffer containing: 20 mM Tris-HCl pH 7.5, 5 mM EDTA, 10 mM
Na4P2O7, 100 mM NaF, 2 mM NaVO4, 0.0015 mM aprotinin, 0.01 mM leupeptin, 3 mM benzamidine,
1 mM phenylmethylsulfonylfluoride, and 1% IGEPAL® CA-630. Samples were rotated end-over-end at
4 ◦C for 60 min and centrifuged at 13,000× g for 30 min. Lysate protein concentrations were determined
via the Bradford method using Bio-Rad protein assay dye (cat#5000006, Bio-Rad Laboratories, Hercules,
CA, USA). Lysates (40 µg) were subjected to SDS-PAGE, and proteins transferred onto 0.2 µm
nitrocellulose membranes. Ponceau S solution (cat#P7170, Sigma-Aldrich, St. Louis, MO, USA) was
utilized to assess equal protein loading and transfer. Immunoblotting conditions were as described
in Table 1. Densitometric analysis of immunoblots was performed using a Bio-Rad Chemidoc XRS+
imaging system and Bio-Rad Image Lab™ software v 6.0.1 (Bio-Rad Laboratories, Hercules, CA, USA).
Table 1. Immunoblotting conditions.
Antigen Blocking 1◦ Antibody 1◦ Antibody RRID 2◦ Antibody ECLReagent













































Antibodies and blotting conditions utilized in the immunoblotting analyses. All bovine serum albumin (BSA) and
non-fat dry milk solutions were made by dissolving the reagent in a 1× Tris-buffered saline solution containing
0.1% Tween-20. Information on the primary antibodies utilized including dilution, solution diluted in, company
name or developer, catalog number, lot number, associated Research Resource Identifiers (RRIDs) or references
providing validation data are indicated in the table. The species, and dilution factor for the horseradish peroxidase
(HRP) conjugated secondary antibodies are indicated in the table. All HRP-conjugated secondary antibodies
were diluted in a 5% BSA, 1× TBS + 0.1% Tween-20 solution. The goat-HRP antibody was cat#PA1-28664,
lot# RK2302292 from ThermoScientific (Waltham, MA, USA). The mouse-HRP antibody was cat#12-349, lot#
2365945 from Millipore (Burlington, MA, USA). The rabbit-HRP antibody was cat#PI31460 (lot# RB230194,
SE251028, SH253595, and TG266717) from Fisher Scientific (Waltham, MA, USA). The enhanced chemiluminescence
(ECL) substrate reagents utilized were either the Western Lightning™ Plus-ECL, cat# NEL105001EA from Perkin
Elmer Life Sciences (Waltham, MA, USA) or the Super Signal™West Femto Chemiluminescent Substrate, cat#
PI34096, from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). G6PD = glucose-6-phosphate dehydrogenase;
GFPT1 = glutamine-fructose-6-phosphate transaminase 1; GLUT = glucose transporter; O-GlcNAc = O-linked
β-N-acetylglucosamine.
Glucose transporter (GLUT) antibodies were previously validated by our group using
mouse tibialis anterior muscle samples overexpressing individual mouse GLUT isoforms [24].
Glucose-6-phosphate dehydrogenase (G6PD) and glutamine fructose-6-phosphate transaminase 1
(GFPT1) antibodies were validated using G6PDx or GFPT1 mouse muscle overexpression samples
that were generated by transfecting the tibialis anterior muscles of male CD-1 mice (8 weeks old)
with empty vector, untagged mouse G6PDx (cat#MC205271, OriGene Technologies, Rockville, MD,
USA), or untagged mouse GFPT1 (cat#MC201036, OriGene Technologies, Rockville, MD, USA) vectors
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followed by standard in vivo muscle gene transfer/ electroporation procedures previously described
by our lab [41,42]. After 1 week, muscles were collected and processed for immunoblot analyses as
described above.
4.10. Statistical Analyses.
Data were graphed using GraphPad Prism v8 software (GraphPad Software Inc., San Diego, CA,
USA) and are presented as individual data points with the mean ± standard deviation. Statistical
significance was assessed using SigmaPlot v12 software (Systat Software Inc., San Jose, CA, USA) and
defined as p < 0.05 determined by Student’s t-tests or Two-way Analysis of Variance and Tukey’s post
hoc analysis. The number of mice or muscles utilized to determine statistical significance is indicated
in the text or figure legends.
5. Conclusions
In conclusion, the results from this study demonstrate that while insulin resistance does not
impair mechanical overload-stimulated increases in skeletal muscle glucose uptake, increases in lactate
secretion, activation of the pentose phosphate pathway or activation of the hexosamine pathway;
it does impair overload-stimulated increases in muscle glycogen synthesis. Future studies are currently
underway to determine the GLUT isoform responsible for overload-stimulated increases in glucose
uptake, as well as to quantify the amount of glucose that is partitioned into each glucometabolic
pathway in response to overload.
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G6PD Glucose-6-phosphate dehydrogenase
GFPT1 Glutamine fructose-6-phosphate transaminase 1
GLUT Glucose transporter
HFD High-fat diet
HOMA-IR Homeostatic model assessment of insulin resistance
KRB Krebs-Ringer-Bicarbonate
LFD Low-fat diet
NADP(H) Nicotinamide adenine dinucleotide phosphate
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
UPLC-MRM/MS Ultra performance liquid chromatography-multiple reaction monitoring mass spectrometry
References
1. Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M.
Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle
intervention or metformin. N. Engl. J. Med. 2002, 346, 393–403.
Int. J. Mol. Sci. 2020, 21, 4715 13 of 15
2. Colberg, S.R.; Sigal, R.J.; Fernhall, B.; Regensteiner, J.G.; Blissmer, B.J.; Rubin, R.R.; Chasan-Taber, L.;
Albright, A.L.; Braun, B.; American College of Sports Medicine; et al. Exercise and type 2 diabetes: The
American College of Sports Medicine and the American Diabetes Association: Joint position statement.
Diabetes Care 2010, 33, e147–e167. [CrossRef] [PubMed]
3. Jorge, M.L.M.P.; de Oliveira, V.N.; Resende, N.M.; Paraiso, L.F.; Calixto, A.; Diniz, A.L.D.; Resende, E.S.;
Ropelle, E.R.; Carvalheira, J.B.; Espindola, F.S.; et al. The effects of aerobic, resistance, and combined exercise
on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with
type 2 diabetes mellitus. Metabolism 2011, 60, 1244–1252. [CrossRef] [PubMed]
4. Bacchi, P.E.; Moghetti, N.C.; Zanolin, M.E.; Milanese, C.; Faccioli, N.; Trombetta, M.; Zoppini, G.; Cevese, A.;
Bonadonna, R.C.; Schena, F.; et al. Metabolic effects of aerobic training and resistance training in type 2
diabetic subjects. Diabetes Care 2012, 35, 676–682. [CrossRef] [PubMed]
5. Baldi, J.; Snowling, N. Resistance training improves glycaemic control in obese type 2 diabetic men. Int. J.
Sports Med. 2003, 24, 419–423.
6. Castaneda, F.; Layne, J.E.; Castaneda, C. Skeletal muscle sodium glucose co-transporters in older adults with
type 2 diabetes undergoing resistance training. Int. J. Med. Sci. 2006, 3, 84–91. [CrossRef]
7. Ferrara, C.M.; Goldberg, A.P.; Ortmeyer, H.K.; Ryan, A.S. Effects of aerobic and resistive exercise training
on glucose disposal and skeletal muscle metabolism in older men. J. Gerontol. Ser. A 2006, 61, 480–487.
[CrossRef]
8. Ishii, T.; Yamakita, T.; Sato, T.; Tanaka, S.; Fujii, S. Resistance training improves insulin sensitivity in NIDDM
subjects without altering maximal oxygen uptake. Diabetes Care 1998, 21, 1353–1355. [CrossRef]
9. Augert, G.; Van de Werve, G.; Le Marchand-Brustel, Y. Effect of work-induced hypertrophy on muscle
glucose metabolism in lean and obese mice. Diabetologia 1985, 28, 295–301. [CrossRef]
10. Holten, M.K.; Zacho, M.; Gaster, M.; Juel, C.; Wojtaszewski, J.F.P.; Dela, F. Strength Training Increases
Insulin-Mediated Glucose Uptake, GLUT4 Content, and Insulin Signaling in Skeletal Muscle in Patients
With Type 2 Diabetes. Diabetes 2004, 53, 294–305. [CrossRef]
11. Patti, M.E.; Virkamäki, A.; Landaker, E.J.; Kahn, C.R.; Yki-Järvinen, H. Activation of the hexosamine pathway
by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal
muscle. Diabetes 1999, 48, 1562–1571. [CrossRef] [PubMed]
12. Cooksey, R.C.; McClain, D.A. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine
synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance. Ann. N. Y. Acad. Sci. 2006,
967, 102–111. [CrossRef]
13. Gulve, E.A.; Ren, J.M.; Marshall, B.A.; Gao, J.; Hansen, P.A.; Holloszy, J.O.; Mueckler, M. Glucose transport
activity in skeletal muscles from transgenic mice overexpressing GLUT1: Increased basal transport is
associated with a defective response to diverse stimuli that activate GLUT4. J. Biol. Chem. 1994, 269,
18366–18370. [PubMed]
14. Barnes, B.R.; Marklund, S.; Steiler, T.L.; Walter, M.; Hjälm, G.; Amarger, V.; Mahlapuu, M.; Leng, Y.;
Johansson, C.; Galuska, D.; et al. The 5′-AMP-activated protein kinase γ3 isoform has a key role in
carbohydrate and lipid metabolism in glycolytic skeletal muscle. J. Biol. Chem. 2004, 279, 38441–38447.
[CrossRef] [PubMed]
15. Buse, M.G.; Robinson, K.A.; Marshall, B.A.; Mueckler, M. Differential effects of GLUT1 or GLUT4
overexpression on hexosamine biosynthesis by muscles of transgenic mice. J. Biol. Chem. 1996, 271,
23197–23202. [CrossRef] [PubMed]
16. Kuo, W.; Lin, J.; Tang, T.K. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3
cells and induces tumors in nude mice. Int. J. Cancer 2000, 85, 857–864. [CrossRef]
17. Tian, W.N.; Braunstein, L.D.; Pang, J.; Stuhlmeier, K.M.; Xi, Q.C.; Tian, X.; Stanton, R.C. Importance of
glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem. 1998, 273, 10609–10617. [CrossRef]
[PubMed]
18. Tixier, V.; Bataille, L.; Etard, C.; Jagla, T.; Weger, M.; DaPonte, J.P.; Strahle, U.; Dickmeis, T.; Jagla, K. Glycolysis
supports embryonic muscle growth by promoting myoblast fusion. Proc. Natl. Acad. Sci. USA 2013, 110,
18982–18987. [CrossRef] [PubMed]
19. Tanner, L.B.; Goglia, A.G.; Wei, M.H.; Sehgal, T.; Parsons, L.R.; Park, J.O.; White, E.; Toettcher, J.E.;
Rabinowitz, J.D. Four key steps control glycolytic flux in mammalian cells. Cell Syst. 2018, 7, 49–62.
[CrossRef]
Int. J. Mol. Sci. 2020, 21, 4715 14 of 15
20. Castaneda, C.; Layne, J.E.; Munoz-Orians, L.; Gordon, P.L.; Walsmith, J.; Foldvari, M.; Roubenoff, R.;
Tucker, K.L.; Nelson, M.E. A randomized controlled trial of resistance exercise training to improve glycemic
control in older adults with type 2 diabetes. Diabetes Care 2002, 25, 2335–2341. [CrossRef]
21. Haun, C.T.; Vann, C.G.; Osburn, S.C.; Mumford, P.W.; Roberson, P.A.; Romero, M.A.; Fox, C.D.; Johnson, C.A.;
Parry, H.A.; Kavazis, A.N.; et al. Muscle fiber hypertrophy in response to 6 weeks of high-volume resistance
training in trained young men is largely attributed to sarcoplasmic hypertrophy. PLoS ONE 2019, 14, e0215267.
[CrossRef] [PubMed]
22. Haun, C.T.; Vann, C.G.; Mobley, C.B.; Osburn, S.C.; Mumford, P.W.; Roberson, P.A.; Romero, M.A.; Fox, C.D.;
Parry, H.A.; Kavazis, A.N.; et al. Pre-training skeletal muscle fiber size and predominant fiber type best
predict hypertrophic responses to 6 weeks of resistance training in previously trained young men. Front.
Physiol. 2019, 10, 297. [CrossRef] [PubMed]
23. Yaspelkis, B.B.; Singh, M.K.; Trevino, B.; Krisan, A.D.; Collins, D.E. Resistance training increases glucose
uptake and transport in rat skeletal muscle. Acta Physiol. Scand. 2002, 175, 315–323. [CrossRef] [PubMed]
24. McMillin, S.L.; Schmidt, D.L.; Kahn, B.B.; Witczak, C.A. GLUT4 is not necessary for overload-induced glucose
uptake or hypertrophic growth in mouse skeletal muscle. Diabetes 2017, 66, 1491–1500. [CrossRef] [PubMed]
25. Chaillou, T.; Lee, J.D.; England, J.H.; Esser, K.A.; McCarthy, J.J. Time course of gene expression during mouse
skeletal muscle hypertrophy. J. Appl. Physiol. 2013, 115, 1065–1074. [CrossRef] [PubMed]
26. Steensberg, A.; van Hall, G.; Keller, C.; Osada, T.; Schjerling, P.; Pedersen, B.K.; Saltin, B.; Febbraio, M.A.
Muscle glycogen content and glucose uptake during exercise in humans: Influence of prior exercise and
dietary manipulation. J. Physiol. 2002, 541, 273–281. [CrossRef] [PubMed]
27. Guillet-Deniau, I.; Leturque, A.; Girard, J. Expression and cellular localization of glucose transporters
(GLUT1, GLUT3, GLUT4) during differentiation of myogenic cells isolated from rat foetuses. J. Cell Sci. 1994,
107, 487–496. [PubMed]
28. Burant, C.F.; Bell, G.I. Mammalian Facilitative Glucose Transporters: Evidence for Similar Substrate
Recognition Sites in Functionally Monomeric Proteins. Biochemistry 1992, 31, 10414–10420. [CrossRef]
[PubMed]
29. Colville, C.A.; Seatter, M.J.; Jess, T.J.; Gould, G.W.; Thomas, H.M. Kinetic analysis of the liver-type (GLUT2)
and brain-type (GLUT3) glucose transporters in Xenopus oocytes: Substrate specificities and effects of
transport inhibitors. Biochem. J. 1993, 290, 701–706. [CrossRef]
30. Maedera, S.; Mizuno, T.; Ishiguro, H.; Ito, T.; Soga, T.; Kusuhara, H. GLUT6 is a lysosomal transporter that is
regulated by inflammatory stimuli and modulates glycolysis in macrophages. FEBS Lett. 2019, 593, 195–208.
[CrossRef]
31. Lisinski, I.; Schurmann, A.; Joost, H.-G.; Cushman, S.W.; Al-Hasani, H. Targeting of GLUT6 (formerly GLUT9)
and GLUT8 in rat adipose cells. Biochem J. 2001, 358, 517–522. [CrossRef] [PubMed]
32. Lee, Y.-C.; Huang, H.-Y.; Chang, C.-J.; Cheng, C.-H.; Chen, Y.-T. Mitochondrial GLUT10 facilitates
dehydroascorbic acid import and protects cells against oxidative stress: Mechanistic insight into arterial
tortuosity syndrome. Hum. Mol. Genet. 2010, 19, 3721–3733. [CrossRef] [PubMed]
33. Scheffer, D.L.; Silva, L.A.; Tromm, C.B.; da Rosa, G.L.; Silveira, P.C.L.; de Souza, C.T.; Latini, A.; Pinho, R.A.
Impact of different resistance training protocols on muscular oxidative stress parameters. Appl. Physiol. Nutr.
Metab. 2012, 37, 1239–1246. [CrossRef]
34. Schwane, J.A.; Armstrong, R.B. Effect of training on skeletal muscle injury from downhill running in rats. J.
Appl. Physiol. 1983, 55, 969–975. [CrossRef] [PubMed]
35. Tsuda, S.; Hayashi, T.; Egawa, T. The effects of caffeine on metabolomic responses to muscle contraction in
rat skeletal muscle. Nutrients 2019, 11, 1819. [CrossRef] [PubMed]
36. Shi, H.; Munk, A.; Nielsen, T.S.; Daughtry, M.R.; Larsson, L.; Li, S.; Høyer, K.F.; Geisler, H.W.; Sulek, K.;
Kjøbsted, R.; et al. Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and
whole-body insulin sensitivity. Mol. Metab. 2018, 11, 160–177. [CrossRef]
37. Garg, N.; Thakur, S.; Alex McMahan, C.; Adamo, M.L. High fat diet induced insulin resistance and glucose
intolerance are gender-specific in IGF-1R heterozygous mice. Biochem. Biophys. Res. Commun. 2011, 413,
476–480. [CrossRef]
38. Hong, J.; Stubbins, R.E.; Smith, R.R.; Harvey, A.E.; Núẽz, N.P. Differential susceptibility to obesity between
male, female and ovariectomized female mice. Nutr. J. 2009, 8, 11. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 4715 15 of 15
39. Pettersson, U.S.; Waldén, T.B.; Carlsson, P.-O.; Jansson, L.; Phillipson, M. Female mice are protected against
high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue.
PLoS ONE 2012, 7, e46057. [CrossRef]
40. Salinero, A.E.; Anderson, B.M.; Zuloaga, K.L. Sex differences in the metabolic effects of diet-induced obesity
vary by age of onset. Int. J. Obes. 2018, 42, 1088–1091. [CrossRef]
41. Ferey, J.L.A.; Brault, J.J.; Smith, C.A.S.; Witczak, C.A. Constitutive activation of CaMKK signaling is sufficient
but not necessary for mTORC1 activation and growth in mouse skeletal muscle. AJP Endocrinol. Metab. 2014,
307, E686–E694. [CrossRef] [PubMed]
42. Hinkley, J.M.; Ferey, J.L.; Brault, J.J.; Smith, C.A.S.; Gilliam, L.A.A.; Witczak, C.A. Constitutively active
CaMKKα stimulates skeletal muscle glucose uptake in insulin-resistant mice in vivo. Diabetes 2014, 63,
142–151. [CrossRef] [PubMed]
43. Hammerstent, R.H. The use of dowex-l-borate from to separate 3HOH from 2-3h-glucose. Anal. Biochem.
1973, 56, 292–293. [CrossRef]
44. Bouskila, M.; Hirshman, M.F.; Jensen, J.; Goodyear, L.J.; Sakamoto, K. Insulin promotes glycogen synthesis
in the absence of GSK3 phosphorylation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2008, 294,
E28–E35. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
